Clinical trial
FMRI of Anosognosia in Amnestic MCI and AD: Focus on Cortical Midline Structures
NCT00908999 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FMRI of Anosognosia in Amnestic MCI and AD: Focus on Cortical Midline Structures
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- September 30, 2011
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, anosognosia, mild cognitive impairment